Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs placebo/open control
Death from any cause · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) showed no clear difference in death from any cause compared with placebo/open control (high certainty).
1 finding from 1 review
- Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage 2023 · Cochrane Headline outcomes onlyRR 1.02 [0.89, 1.18]8 studies · 2866 participantsHigh